Background/Objectives: Bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) affect the prognosis of preterm infants, and their coexistence is a risk factor for poor long-term outcomes in very low-birth-weight infants. However, there has been limited in-depth assessment of common and independent risk factors for BPD and ROP within the same cohort. Therefore, we aimed to investigate the risk factors for BPD and ROP in very low-birth-weight infants born at ≤32 weeks of gestation and to explore the interaction between these two diseases. Methods: The participants were divided into four groups: BPD+ROP+, BPD-ROP-, BPD+ROP-, and BPD-ROP+. Gestational age, birth weight, maternal pregnancy complications, birth and postnatal diseases, and treatment conditions were compared among the groups. Subsequently, univariate and multivariate binary logistic regression analyses were conducted to explore the independent risk factors for BPD and ROP. Results: Common risk factors of BPD and ROP included gestational age and prolonged oxygen therapy. The multivariate analysis revealed that gestational age (OR: 4.44; 95% CI: 3–6.57), intubation resuscitation (OR: 2.35; 95% CI: 1.09–5.05), mechanical ventilation duration ≥ 7 days (OR: 1.01; 95% CI: 1.01–1.01), and prolonged total oxygen therapy (OR: 3.13; 95% CI: 1.28–7.64) were independent risk factors for BPD. Additionally, gestational age (OR: 0.66; 95% CI: 0.54–0.81) and prolonged oxygen therapy (OR: 1.02; 95% CI: 1–1.03) were independent risk factors for ROP. Conclusions: The proper control of the duration and concentration of oxygen therapy, along with the minimization of mechanical ventilation time, is crucial for reducing the incidence of both BPD and ROP.
Background/Objectives: Retinopathy of prematurity (ROP) remains an important cause of preventable childhood visual impairment, yet recent temporal changes among very-low-birth-weight infants in China are not well characterized. This study aimed to evaluate temporal changes in screen-detected ROP among very-low-birth-weight infants born before 32 weeks of gestation. Methods: We conducted a single-center retrospective cohort study of very-low-birth-weight infants who underwent ROP screening at Peking University Third Hospital from 2021 to 2024. Infants were grouped by birth period, and sequential multivariable regression models and sensitivity analyses were used to assess temporal differences in ROP outcomes. Results: Among 614 infants assessed for eligibility, 478 screened infants with available ROP outcomes were included. Any-stage ROP increased from 34.3% in 2021–2022 to 64.6% in 2023–2024 (p < 0.001). The association remained statistically significant in the sequential explanatory Model 6 (OR 2.82, 95% CI 1.73–4.60; p < 0.001). Treatment-requiring ROP showed a nonsignificant numerical increase from 5.1% to 9.3% (p = 0.112). Among infants with ROP, documented pre-plus findings were more frequent in 2023–2024 than in 2021–2022 (15.5% vs. 4.4%), and the overall plus-status distribution differed between periods (p = 0.040); however, maximum ROP stage and treatment-requiring ROP did not differ significantly. Conclusions: Screen-detected any-stage ROP increased substantially in 2023–2024, with more frequent documented pre-plus findings but no statistically significant increase in treatment-requiring ROP or other predefined severe indicators.